| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |